Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
142.00    2.00 (1.43%)
Bid:
140.00
Ask:
142.00
Spread: 2.00 (1.429%)
Market Cap: £272.19m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

Director/PDMR Shareholding

14 Sep 2017 10:49

RNS Number : 7635Q
Franchise Brands PLC
14 September 2017
 

14 September 2017

 

Franchise Brands plc

("Franchise Brands", the "Company" or "Group")

 

Director/PDMR shareholding

 

Franchise Brands plc (AIM: FRAN) has been informed that Chris Dent, Chief Financial Officer of the Group, has today purchased 15,000 ordinary shares in the Company ("Ordinary Shares") at a price of 64.5p per share. Following this purchase, Mr Dent now has a total beneficial interest in 15,000 Ordinary Shares, equivalent to 0.02% of the Company's issued share capital.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Chris Dent

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Franchise Brands plc

b)

LEI

n/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.5p each in Franchise Brands plc

 

Identification code (ISIN) for Franchise Brands plc ordinary shares: GB00BD6P7Y24

b)

Nature of the transaction

Purchase of shares

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

64.5p

15,000

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

14 September 2017

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

The information set out in this announcement is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

 

Enquiries:

 

Franchise Brands plc

+44 (0) 800 012 6462

Stephen Hemsley, Executive Chairman

Chris Dent, Chief Financial Officer

Julia Choudhury, Corporate Development Director

Allenby Capital Limited (Nominated Adviser and Joint Broker)

+44 (0) 203 328 5656

Jeremy Porter/ James Thomas/ Liz Kirchner

Dowgate Capital Stockbrokers (Joint Broker)

+44 (0) 203 903 7715

James Serjeant

MHP Communications (Financial PR)

+44 (0) 203 128 8100

Katie Hunt/Ivana Petkova

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGCGDCISBBGRS
Date   Source Headline
2nd Apr 20259:00 amRNS-RInvestor Presentation via Investor Meet Company
1st Apr 20252:19 pmRNSAnnual Report and Accounts & Notice of AGM
31st Mar 202510:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSFinal Results
17th Mar 20257:00 amRNSNotice of Results
25th Feb 20253:47 pmRNSHolding(s) in Company
20th Feb 20252:30 pmRNSCapital Markets Day
13th Feb 20257:00 amRNSAppointment of CFO and Group Finance Director
11th Feb 20257:00 amRNSDirector/PDMR Shareholding
7th Feb 20257:00 amRNS-RCapital Markets Day
31st Jan 20257:00 amRNSDirectors’ dealings
28th Jan 20257:00 amRNSTrading Update
16th Jan 20257:00 amRNSAppointment of Non-Executive Director
13th Nov 20242:00 pmRNSGrant of Options to director
12th Nov 20247:00 amRNSQ3 Trading Update
23rd Oct 20247:00 amRNSGroup CEO Appointment and Listing Consideration
15th Oct 20247:00 amRNSRe-commencement of Share purchase programme
23rd Sep 202411:54 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSDirector/PDMR shareholding & holding in Company
17th Sep 20247:00 amRNSInterim Results
9th Sep 20247:00 amRNSNotice of Interim Results
30th Jul 20248:33 amRNSDirector/PDMR Shareholding
18th Jul 20241:55 pmRNSResult of AGM
18th Jul 20247:00 amRNSAGM Statement and Trading Update
8th Jul 20241:42 pmRNSGrant of Options
27th Jun 202410:01 amRNSAnnual General Meeting and proxy voting deadline
21st Jun 20244:40 pmRNSPublication of Annual Report and Accounts
20th Jun 20247:01 amRNSBoard and management changes
20th Jun 20247:00 amRNSFinal Results
3rd Jun 20247:00 amRNSTrading Update, Final Dividend & AGM
4th Apr 20243:02 pmRNSHolding(s) in Company
20th Feb 20242:45 pmRNSCapital Markets Day
18th Jan 20247:00 amRNSCapital Markets Day
18th Jan 20247:00 amRNSTrading Update
16th Jan 20245:12 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSInvestor presentation
15th Nov 20233:11 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSQ3 Trading Update
4th Sep 20237:00 amRNSBoard and management update
4th Aug 20237:00 amRNSDirector/PDMR Shareholding and Grant of Options
27th Jul 20237:01 amRNSAppointment of Chief Financial Officer
27th Jul 20237:00 amRNSInterim Results
25th Jul 20231:51 pmRNSInvestor Presentation via Investor Meet Company
5th Jul 20237:00 amRNSNotice of Interim Results
26th Jun 20237:00 amRNSShare Purchase Programme
1st Jun 20237:00 amRNSDirector/PDMR Shareholding
18th May 202310:10 amRNSHolding(s) in Company
10th May 20235:54 pmRNSGrant of options & director holdings
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20235:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.